Laman UtamaORCHPHARMA • NSE
add
Orchid Pharma Ltd
Tutup sebelumnya
₹705.80
Julat hari
₹705.55 - ₹718.55
Julat tahun
₹603.80 - ₹1,997.40
Permodalan pasaran
35.79B INR
Bilangan Purata
63.25K
Nisbah P/E
41.98
Hasil dividen
-
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.73B | -29.25% |
Perbelanjaan pengendalian | 685.42J | -2.23% |
Pendapatan bersih | 149.11J | -49.20% |
Margin untung bersih | 8.62 | -28.23% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 141.58J | -55.75% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.80B | 4,871.20% |
Jumlah aset | — | — |
Jumlah liabiliti | — | — |
Jumlah ekuiti | 12.67B | — |
Syer tertunggak | 50.72J | — |
Harga kepada buku | 2.82 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 0.96% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 149.11J | -49.20% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Diasaskan
1992
Tapak web
Pekerja
736
